Publication | Closed Access

A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration

Ocular DiseaseVitreous BodyOphthalmologyExperimental OphthalmologyAge-related DiseasesGlaucomaMedicineAflibercept Injections